Feed Top Reports Pricing

⌘K

08:54:29·192d

ANALYSTRating

Needham initiated coverage on MindMed with a new price target

MNMD· Mind Medicine (MindMed) Inc.

Health Care

Original source

Companies

MNMD
Mind Medicine (MindMed) Inc.
Health Care

Recent analyst ratings

Oct 13UpdateNeedham$28.00
Aug 4UpdateOppenheimer$25.00
Jan 28UpdateEvercore ISI$23.00
Dec 20UpdateChardan Capital Markets$20.00
Oct 14UpdateLeerink Partners$20.00
Jul 24UpdateROTH MKM$36.00

Related

SEC101d
Mind Medicine (MindMed) Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits
INSIDER115d
Chief Legal Officer Sullivan Mark sold $148,244 worth of shares (11,276 units at $13.15), decreasing direct ownership by 4% to 282,576 units (SEC Form 4)
INSIDER115d
Chief Executive Officer Barrow Robert sold $339,072 worth of shares (25,791 units at $13.15), decreasing direct ownership by 3% to 778,477 units (SEC Form 4)
INSIDER115d
Chief Medical Officer Karlin Daniel sold $73,623 worth of shares (5,600 units at $13.15), decreasing direct ownership by 1% to 425,025 units (SEC Form 4)
SEC115d
SEC Form 144 filed by Mind Medicine (MindMed) Inc.
PR126d
MindMed to Present at the 44th Annual J.P. Morgan Healthcare Conference
PR129d
MindMed Announces New Employee Inducement Grant
PR143d
MindMed Announces New Employee Inducement Grants

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds

Top lists

Trending By market cap Active companies Analyst upgrades Insider purchases FDA approvals SEC filings Sectors Market reports

Company

About Pricing Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022